Abstract:
The present invention relates to a method for separating ginsenoside from a ginseng extract in one step using a counter-current chromatography. A certain amount and more of high purity of 14 kinds of ginsenoside can be obtained within a short time (100-400 minutes) through one chromatography process without going through a special process. Moreover, an expensive column with a limited reuse is not needed, and the use of a solvent is drastically reduced.
Abstract:
길경 추출물로부터 분리되는 길경 사포닌 분획물 및 이 분획물로부터 효소에 의하여 생전환 시킨 고함량의 플라티코딘 D를 유효성분으로 함유하는 지질대사 질환의 예방 및 치료용 조성물에 관한 것으로서, 상세하게는 본 발명의 길경 추출물로부터 분리되는 길경 사포닌 분획물 및 이 분획물로부터 효소에 의하여 생전환 시킨 고함량의 플라티코딘 D 강화 분획물은 지방세포 분화 억제 효과가 탁월하므로, 상기 조성물은 지질대사 질환의 예방 및 치료용 약학조성물 및 건강기능식품으로 유용하게 이용될 수 있다. 길경 추출물, 길경 사포닌 분획물, 플라티코딘 D, 지방세포 분화, 지질대사 질환
Abstract:
PURPOSE: A ginseng extract containing low polarity ginsenoside in high concentration, which has anti-obesity effect is provided to reduce the accumulation of lipid in an adipocyte and used as a composition for anti-obesity. CONSTITUTION: A method for manufacturing a ginseng extract comprises: a step of extracting a ginseng with 20-40 v/v% of methanol or ethanol and 80 ~ 99 v/v% of methanol or ethanol; a step of culturing the extract in pH 1.3-2 of artificial gastric juice; and a step of adding serous fluid and culturing at pH 7-8.
Abstract:
PURPOSE: A silver nanoparticle using chondroitin sulfate or acharan sulfate is provided to suppress bacteria without toxicity and to enable quick wound healing. CONSTITUTION: A biocompatible silver nanoparticle improves safety, stability, and wound healing effect using chondroitin sulfate or acharan sulfate. The size of the silver nanoparticle is 5-50 nm. A method for preparing the silver nanoparticles comprises: a step of dissolving chondroitin sulfate or acharan sulfate in 0.01-2.0 mM of distilled water to prepare a reducing agent solution; a step of dissolving 0.01-10.0 mM nitric acid in distilled water to prepare a nitric acid solution; a step of mixing the reducing agent solution and nitric acid solution to prepare a mixture solution; and a step of reacting the mixture solution in an autoclave or microwave.
Abstract:
PURPOSE: A cosmetic composition containing demethoxycurcumin or bisdemethoxycurcumin for anti-wrinkling is provided to suppress expression of collaganase without toxicity. CONSTITUTION: A cosmetic composition for anti-wrinkling contains 0.000001-10.0 weight% of demethoxycurcumin of chemical formula 1 or bisdemethoxycurcumin of chemical formula 2 as an active ingredient. The cosmetic composition is used in the form of cream, lotion, essence, gel, ointment, foam, pack, emulsion, foundation, makeup base, soap, or sun screen.
Abstract:
PURPOSE: A composition containing platycodin D for preventing and treating bone diseases is provided to reduce bone absorption and to suppress osteoclasia. CONSTITUTION: A composition for preventing or treating bone diseases contains platycodin D as an active ingredient. The platycodin D is contained in Platycodon grandiflorum extract. The Platycodon grandiflorum extract is obtained by isolating with water, butane, ethyl acetate, or mixture thereof. The bone diseases are bone injury, osteoporosis, richets, malacosteon, or metabolic bone diseases. A pharmaceutical composition for preventing and treating bone diseases contains therapeutically effective amount of the composition and pharmaceutically acceptable carrier.
Abstract:
A method for refining horse oil is provided to produce refined horse oil of which a human body absorption property is high, to remove a saturated fatty acid and a free fatty acid using an ultra-precision control crystallization, to increase a validity of the horse oil and the human body absorption property, to enhance an yield while commercial production, to generate no waste water and to cause no color and smell. A method for refining horse oil comprises steps of: i) adding urea in horse oil and reacting it; ii) removing a crystal by filtering the reaction solution of the step i); iii) adding activated charcoal and activated clay in a filtrate of the step ii) and reacting it at a vacuum pressure; iv) removing the activated clay and the activated charcoal using a filtering process; v) cooling the filtrate of the step iv) at a room temperature; vi) adding water to the filtrate of the step v) additionally and performing evaporation of a thin film under the vacuum pressure.